Quiver Bioscience
Cambridge, Massachusetts, United States · Artificial Intelligence, Biotechnology, Health Care · 135 employees
Quiver Bioscience is a technology-driven company established to create transformational medicines for the brain while simultaneously uncovering new biology and novel, effective drug targets. Using advanced single-cell imaging and multi-omics, we are building the world's most information-rich neuronal insight map via our "Genomic Positioning System." Our approach integrates cutting-edge scalable hu
Funding history
- Corporate Round — Undisclosed — Apr 2026
- Grant — $2.2M — Jul 2025
Recent signals
- Apr 13, 2026: Raised funding in Corporate Round
- Jul 01, 2025: Raised $2.2M in Grant
- Jun 17, 2025: Quiver Bioscience Appoints Graham Dempsey as Chief Executive Officer
- Nov 21, 2024: Launched Quiver Bioscience Showcases Genomic Positioning System for Therapeutics in Fragile X Syndrome via Publication in Nature Communications Biology.
See plans & pricing → Track Quiver Bioscience’s funding, hiring, and signals — with verified contacts — on Fundz.